Which groundbreaking medical product launch in 2012 was the first FDA-approved gene therapy treatment for a specific form of blindness?

The healthcare industry has witnessed remarkable product launches that have revolutionized patient care and treatment approaches. From diagnostic tools to therapeutic innovations, these product milestones mark significant advances in medical science. Test your knowledge about one of the most transformative product launches in modern medicine that has fundamentally changed how we approach certain diseases.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Luxturna (voretigene neparvovec) by Spark Therapeutics
• Kymriah (tisagenlecleucel) by Novartis
• Yescarta (axicabtagene ciloleucel) by Kite Pharma
• Spinraza (nusinersen) by Biogen

Powered by AIPolls.Net — AI-powered real-time polling platform.